AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion ...
That’s what has fascinated the editors of Canada’s Top 100 Employers since the annual competition launched in 2000 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback